We are live on
!
Find out more
IAM
Iridian Asset Management Portfolio holdings
AUM
$291M
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+2.99%
1 Year Est. Return
+49.45%
3 Year Est. Return
+82.55%
5 Year Est. Return
+101.12%
10 Year Est. Return
+450.66%
AUM
$11.8B
AUM Growth
-$408M
(-3.4%)
Cap. Flow
-$576M
Cap. Flow
% of AUM
-4.9%
Top 10 Holdings %
Top 10 Hldgs %
41.76%
Holding
73
New
7
Increased
26
Reduced
22
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$271M |
| 2 |
Axalta
AXTA
|
+$140M |
| 3 |
Albemarle
ALB
|
+$137M |
| 4 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$120M |
| 5 |
Packaging Corp of America
PKG
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$440M |
| 2 |
SNDK
SANDISK CORP
SNDK
|
+$393M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$232M |
| 4 |
Martin Marietta Materials
MLM
|
+$177M |
| 5 |
Micron Technology
MU
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.87% |
| 2 | Materials | 15.25% |
| 3 | Industrials | 14% |
| 4 | Technology | 11.76% |
| 5 | Healthcare | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visteon
VC
$2.79B
| $195M | 1.66% |
2,445,702
+291,307
| +14% | +$22.9M |
|
|
MDRX
27
DELISTED
Veradigm Inc. Common Stock
MDRX
| $190M | 1.62% |
14,401,161
-1,219,015
| -8% | -$16M |
|
28
Air Products & Chemicals
APD
$65.7B
| $186M | 1.58% |
1,394,730
+490,185
| +54% | +$59.3M |
|
29
Myriad Genetics
MYGN
$270M
| $169M | 1.43% |
4,508,349
+617,277
| +16% | +$23.3M |
|
|
30
Albemarle
ALB
$13.9B
| $160M | 1.36% |
+2,498,934
| New | +$137M |
|
31
Innoviva
INVA
$1.55B
| $153M | 1.3% |
12,182,146
-237,699
| -2% | -$2.61M |
|
|
ALR
32
DELISTED
Alere Inc
ALR
| $150M | 1.27% |
2,958,281
-625,857
| -17% | -$30M |
|
33
Herc Holdings
HRI
$5.02B
| $137M | 1.16% |
4,329,693
-760,736
| -15% | -$22.3M |
|
|
GCP
34
DELISTED
GCP Applied Technologies Inc.
GCP
| $131M | 1.12% |
+6,581,100
| New | +$120M |
|
35
Precigen
PGEN
$2.24B
| $131M | 1.11% |
3,889,407
+404,058
| +12% | +$12.7M |
|
36
Avis
CAR
$4.86B
| $129M | 1.09% |
4,699,582
-1,830,005
| -28% | -$50M |
|
37
Seagate
STX
$194B
| $120M | 1.02% |
3,486,404
+3,456,404
| +11,521% | +$111M |
|
38
NCR Voyix
VYX
$1.14B
| $118M | 1% |
6,415,923
+64,082
| +1% | +$919K |
|
|
BXLT
39
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $107M | 0.91% |
2,647,749
-867,415
| -25% | -$34.3M |
|
|
VSTO
40
DELISTED
Vista Outdoor Inc.
VSTO
| $102M | 0.87% |
1,961,261
-616,065
| -24% | -$29.7M |
|
|
SEMG
41
DELISTED
SEMGROUP CORPORATION
SEMG
| $97.5M | 0.83% |
4,354,336
-22,245
| -0.5% | -$459K |
|
42
Halozyme
HALO
$9.79B
| $82.8M | 0.7% |
8,745,524
+61,340
| +0.7% | +$577K |
|
43
Newell Brands
NWL
$2.38B
| $72.1M | 0.61% |
+1,627,926
| New | +$63.8M |
|
|
DCP
44
DELISTED
DCP Midstream, LP
DCP
| $5.29M | 0.05% |
194,455
+55,020
| +39% | +$1.15M |
|
45
Biogen
BIIB
$30B
| $4.17M | 0.04% |
16,000
+2,000
| +14% | +$528K |
|
46
Amgen
AMGN
$208B
| $3.75M | 0.03% |
25,000
| – | – |
|
|
AGN
47
DELISTED
Allergan plc
AGN
| $3.22M | 0.03% |
12,000
-3,000
| -20% | -$859K |
|
48
CrossAmerica Partners
CAPL
$847M
| $3M | 0.03% |
123,130
+8,835
| +8% | +$195K |
|
49
CVS Health
CVS
$133B
| $2.08M | 0.02% |
20,000
| – | – |
|
50
Texas Instruments
TXN
$252B
| $2.01M | 0.02% |
35,000
| – | – |
|
Similar funds
DP
DWM
EPIME
DIGDR
LFC
ACG
ODFS
FPM
Iridian Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Iridian Asset Management held 73 positions worth $11.8B, down 3.4% from $12.2B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Iridian Asset Management withdrew a net $576M in Q1 2016, closing 9 positions and reducing 22 holdings. Its most notable exit was Bausch Health, an estimated $440M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 29% a quarter earlier, followed by Materials and Industrials.
Against the trend, Iridian Asset Management opened a new position in Yahoo Inc worth $318M.
- Iridian Asset Management's largest Q1 2016 buy was Yahoo Inc: 8,649,079 shares worth $318M.
- Iridian Asset Management added most to Axalta in Q1 2016, an estimated $140M increase.
- Iridian Asset Management's biggest Q1 2016 reduction was Martin Marietta Materials, cutting an estimated $177M.
- Iridian Asset Management fully exited Bausch Health in Q1 2016, selling an estimated $440M.
- Iridian Asset Management's ten largest holdings make up 42% of its $11.8B portfolio in Q1 2016.
- Iridian Asset Management opened 7 new positions and closed 9 in Q1 2016.
- Iridian Asset Management's portfolio value fell 3.4% quarter-over-quarter to $11.8B.
Based on Iridian Asset Management's 13F filing for Q1 2016, filed 10 May 2016.